Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma.
Tempescul
Adrian
A
Department of Clinical Hematology, Institute of Cancerology and Hematology, CHU Morvan, Brest, France. tempescul@hotmail.com
Ianotto
Jean-Christophe
JC
Morel
Frederic
F
Marion
Veronique
V
De Braekeleer
Marc
M
Berthou
Christian
C
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000235:genetics; D012008:Recurrence; D012074:Remission Induction; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide